Viatris Inc Revenue Growth Rates (VTRS), Current and Historic Growth - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• Revenue Y/Y
• Op. Income Y/Y
• Cop. Income Y/Y
• Net Income Y/Y
• Eps Cop. Y/Y
• Eps Net Y/Y
• Free Cash Flow Y/Y
• Cash Flow Y/Y
• Capex Y/Y
• Sales Y/Y Annual
Viatris Inc   (NASDAQ: VTRS)
 

VTRS's Revenue Growth by Quarter and Year

Viatris Inc 's Revenue results by quarter and year



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

VTRS Revenue (in millions $) FY 2026 FY 2025 FY 2024 FY 2023
4th Quarter December -
3rd Quarter September -
2nd Quarter June 3,756.80
1st Quarter March 3,517.00
FY 7,273.80

VTRSs Annual Revenue
Viatris Inc 's Revenue in the fiscal year 2025 $ 14,299.90 millions
Viatris Inc 's Revenue in the fiscal year 2024 $ 14,739.30 millions
Viatris Inc 's Revenue in the fiscal year 2023 $ 15,426.90 millions
Viatris Inc 's Revenue in the fiscal year 2022 $ 16,262.70 millions
Viatris Inc 's Revenue in the fiscal year 2021 $ 17,886.30 millions




VTRS Revenue second quarter 2026 Y/Y Growth Comment
Viatris Inc achieved in the second quarter 2026, above Company average Revenue improvement of 4.88% year on year, to $ 3,756.80 millions.

Looking into second quarter 2026 results within Major Pharmaceutical Preparations industry 122 other companies have achieved higher Revenue growth. While Viatris Inc ' s Revenue increase of 4.88% ranks overall at the positon no. 2732 in the second quarter 2026.


VTRS Revenue ( Y/Y Growth %) 2026
 2025 2024 2023
4th Quarter December - 4.97 % -8.06 % -1 %
3rd Quarter September - 0.23 % -4.84 % -3.34 %
2nd Quarter June 4.88 % -5.65 % -3.11 % -4.81 %
1st Quarter March 8.07 % -11.17 % -1.76 % -11.04 %
FY   - -2.98 % -4.46 % -

Financial Statements
Viatris Inc 's second quarter 2026 Revenue $ 3,756.80 millions VTRS's Income Statement
Viatris Inc 's second quarter 2025 Revenue $ 3,582.10 millions Quarterly VTRS's Income Statement


VTRS Revenue (Quarter on Quarter Growth %)

 2026
 2025 2024 2023
4th Quarter December - -1.5 % -5.95 % -2.65 %
3rd Quarter September - 4.96 % -1.2 % 0.59 %
2nd Quarter June 6.82 % 10.07 % 3.64 % 5.08 %
1st Quarter March -5.04 % -7.76 % -4.53 % -3.79 %
FY (Year on Year)   - -2.98 % -4.46 % -


Back to VTRS Growth rate Comparisons >> Back to VTRS Growth rate Comparisons >>


Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #123
Healthcare Sector #390
Overall #2732

Revenue Y/Y Growth Statistics
High Average Low
4.4 % -8.7 % -34.37 %
  (Sep 30 2022)
Revenue second quarter 2026 Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #123
Healthcare Sector #390
Overall #2732
Revenue Y/Y Growth Statistics
High Average Low
4.4 % -8.7 % -34.37 %
  (Sep 30 2022)

Revenue by Quarter for the Fiscal Years 2023, 2024, 2025, 2026

Viatris Inc 's Q/Q Revenue Growth


Revenue Q/Q Growth Statistics
High Average Low
301.94 % 9.51 % -62.91 %
(Dec 31 2020)  


VTRS's II. Quarter Q/Q Revenue Comment
Viatris Inc achieved in the II. Quarter 2026 below company average Revenue increase of 6.82% quarter on quarter, to $ 3,756.80 millions.

Within Major Pharmaceutical Preparations industry 62 other companies have achieved higher Revenue quarter on quarter growth. While Viatris Inc 's Revenue growth quarter on quarter, overall rank is 1007.


Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #63
Healthcare Sector #151
Overall #1007
Revenue Q/Q Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry #63
Healthcare Sector #151
Overall #1007
Revenue Q/Q Growth Statistics
High Average Low
301.94 % 9.51 % -62.91 %
(Dec 31 2020)  


VTRS's II. Quarter Q/Q Revenue Comment
Viatris Inc achieved in the II. Quarter 2026 below company average Revenue increase of 6.82% quarter on quarter, to $ 3,756.80 millions.

Within Major Pharmaceutical Preparations industry 62 other companies have achieved higher Revenue quarter on quarter growth. While Viatris Inc 's Revenue growth quarter on quarter, overall rank is 1007.


Viatris Inc 's 12 Months Revenue Growth Year on Year


Revenue TTM Growth

12 Months Ending
(Jun 30 2026)		 12 Months Ending
(Mar 31 2026)		 12 Months Ending
(Dec 31 2025)		 12 Months Ending
(Sep 30 2025)		 12 Months Ending
(Jun 30 2025)
Cumulative Revenue 12 Months Ending $ 14,737.30 $ 14,562.60 $ 14,299.90 $ 14,124.40 $ 14,115.70
Y / Y Revenue Growth (TTM) 4.4 % 1.62 % -2.98 % -6.14 % -7.37 %
Year on Year Revenue Growth Overall Ranking # 3065 # 2743 # 1658 # 1719 # 2043
Seqeuential Revenue Change (TTM) 1.2 % 1.84 % 1.24 % 0.06 % -1.5 %
Seq. Revenue Growth (TTM) Overall Ranking # 2732 # 2698 # 2405 # 2319 # 1941


Cumulative Revenue growth Comment
With 4.4% annual Revenue growth, Viatris Inc would report a record annual Revenue improvement if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 419 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2743 to 3065.

Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 123
Healthcare Sector # 420
Overall # 3065

Revenue TTM Y/Y Growth Statistics
High Average Low
4.4 %
 -8.7 %
-34.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 123
Sector # 390
S&P 500 # 2732
Cumulative Revenue growth Comment
With 4.4% annual Revenue growth, Viatris Inc would report a record annual Revenue improvement if the fiscal year would end on Jun 30 2026.

In the Healthcare sector 419 other companies have achieved higher trailing twelve month Revenue growth. While Revenue growth total ranking has deteriorated compare to previous quarter from 2743 to 3065.


Revenue TTM Y/Y Growth Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 123
Healthcare Sector # 420
Overall # 3065

Revenue TTM Y/Y Growth Statistics
High Average Low
4.4 %
-8.7 %
-34.37 %
 


Revenue TTM Q/Q Growth Company Ranking
Within: No.
Industry # 123
Sector # 390
S&P 500 # 2732




Other Revenue Growth
Major Pharmaceutical Preparations Industry Revenue Growth Trends and Statistics
Healthcare Sector Revenue Growth Statistics
Revenue Growth Trends for overall market
VTRS's Revenue Growth Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Revenue Growth
Lowest Ranking Revenue Growth




Companies with similar Revenue improvement for the quarter ending Jun 30 2026 within Healthcare SectorY/Y Change %Revenue for the quarter ending Jun 30 2026
Maravai Lifesciences Holdings Inc 8.53%$ 8.534 millions
U S Physical Therapy Inc8.47%$ 8.470 millions
Ocugen Inc 8.38%$ 8.376 millions
Baxter International Inc 8.36%$ 8.363 millions
Carlisle Companies Incorporated8.33%$ 8.334 millions
Universal Health Services Inc 8.27%$ 8.268 millions
Addus Homecare Corp8.18%$ 8.181 millions
Puma Biotechnology Inc 7.75%$ 7.754 millions
Cryoport inc 7.74%$ 7.737 millions
Schrodinger Inc 7.54%$ 7.542 millions
Boston Scientific Corporation7.53%$ 7.528 millions
Agilon Health Inc 7.15%$ 7.151 millions
Tenet Healthcare Corp6.77%$ 6.773 millions
Henry Schein Inc 6.73%$ 6.728 millions
Collegium Pharmaceutical Inc 6.67%$ 6.668 millions
Mallinckrodt Plc6.62%$ 6.617 millions
Johnson and Johnson6.60%$ 6.600 millions
Prestige Consumer Healthcare Inc 6.57%$ 6.569 millions
Msa Safety Inc6.25%$ 6.252 millions
Pacira Biosciences inc 6.24%$ 6.240 millions
Globus Medical Inc 5.94%$ 5.940 millions
Labcorp Holdings Inc 5.78%$ 5.778 millions
Tandem Diabetes Care Inc 5.77%$ 5.768 millions
Bristol myers Squibb Company5.74%$ 5.738 millions
Haemonetics Corporation5.65%$ 5.646 millions
Progyny Inc 5.58%$ 5.584 millions
Cytek Biosciences Inc 5.57%$ 5.566 millions
Amphastar Pharmaceuticals Inc 5.44%$ 5.441 millions
Becton Dickinson And Company5.44%$ 5.438 millions
Bruker Corporation5.22%$ 5.220 millions


About Viatris Inc Revenue Growth Rates (VTRS), Current and Historic Growth - CSIMarket Analysis

How we calculate this

This page is based on issuer-reported fundamentals and CSIMarket’s U.S. equities database (20+ years). Growth is computed using year-over-year (Y/Y), sequential, and trailing-twelve-month (TTM) methods.

What’s included here

Company: Viatris Inc (CIK 1792044).

Source & verification

Last updated

  • Page updated:
  • Data lineage: SEC filings → XBRL parse → normalization CSIMarket.com Database → growth calculations.
  • Accession: 0001792044-26-000041
  • Figures are derived from filed reports and may be restated; numbers are subject to revision.

Sources: Viatris Inc’s SEC filings (XBRL/Inline XBRL) and CSIMarket.com’s normalization & QA processes.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.